The new starters bring the total of new team members to 21 at MRN this year alone, as the firm continues its transatlantic growth plans.
At MRN’s UK headquarters in Milton Keynes there are eight new hires: Jo Carter and Sue Lafferty join as a Project Managers, Charlotte Geen and Eleni Katsis both join as Project Support Associates; Matimba Swana joins as Business Development Executive, Rebecca Veall as Vendor and Contracts Associate, Harriet Wylie as Analyst and Fraser Wylie as Proposals and Contracts Associate.
In MRN’s Chicago office, new starters include Jennifer Kilgore joining MRN as a Project Manager, Saketh Gudipati as a Project Support Associate and Leigh Schnake as an Executive Assistant.
On joining MRN, Jo Carter, a clinical trial manager with over 15 years’ experience within the Pharmaceutical, Biotechnology and Contract Research industries, said: "Working with MRN gives me the opportunity to draw from my global experience of managing and monitoring Phase I-IV clinical trials, in a variety of therapeutic areas. I am currently managing a number of global rare disease clinical trials. Having worked in Europe, US and Australia I have a good understanding of the problems faced by sites in conducting complex trials and I am excited about the work that MRN is involved with globally."
Dr Graham Wylie, CEO of MRN, said: "It was always our plan to expand our team both in the UK and US this year and we’re very satisfied with the calibre of people we’ve been able to attract to MRN. Throughout 2016 we will be further rolling out our global reach in community-based trials and our growing team will play a vital role in helping us do this."
Speaking about her new role, Charlotte Geen said: "I graduated the summer of 2014 and have since interned for the NHS, which has confirmed that the healthcare sector is where I want to continue working. I am really enjoying the fast-paced environment of MRN and am looking forward to the challenges that come with working within clinical trials."
Established in 2006, MRN provides global home healthcare and site nurse solutions. Taking the trial to the patient makes participation more convenient and appealing for the patients and boosts recruitment rates considerably (from 60% upwards). This ease of participation also significantly improves patient retention, consistently above 95%.
For more information about vacancies at MRN and the services it provides visit www.themrn.co.uk.